Technical Analysis for LYRA - Lyra Therapeutics, Inc.

Grade Last Price % Change Price Change
grade F 11.0 -4.35% -0.50
LYRA closed down 4.35 percent on Thursday, October 29, 2020, on 3.1 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Down Down
Historical LYRA trend table...

Date Alert Name Type % Chg
180 Bearish Setup Bearish Swing Setup 0.00%
Volume Surge Other 0.00%
Stochastic Reached Oversold Weakness 0.00%
Down 3 Days in a Row Weakness 0.00%
Oversold Stochastic Weakness 0.00%
MACD Bearish Centerline Cross Bearish -4.35%
Hammer Candlestick Bullish -4.35%
Lizard Bullish Bullish Day Trade Setup -4.35%
Volume Surge Other -4.35%
Narrow Range Bar Range Contraction -4.35%
Older End-of-Day Gignals for LYRA ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
50 DMA Resistance 6 days ago
Rose Above Previous Day's High 6 days ago
Up 1% 6 days ago
Rose Above 50 DMA 7 days ago
Down 1% 7 days ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Lyra Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions using XTreo technology platform for the localized treatment of patients with ear, nose, and throat diseases. Its XTreo platform is designed to deliver medicines directly to the affected tissue for sustained periods with a single administration. The company's product candidates include LYR-210 and LYR-220, which are bioresorbable polymeric matrices for the treatment of chronic rhinosinusitis. Lyra Therapeutics, Inc. was founded in 2005 and is headquartered in Watertown, Massachusetts.
Sinusitis Chronic Rhinosinusitis Headaches

Is LYRA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 22.0
52 Week Low 10.44
Average Volume 23,708
200-Day Moving Average 0.00
50-Day Moving Average 12.10
20-Day Moving Average 11.90
10-Day Moving Average 12.09
Average True Range 0.66
ADX 20.78
+DI 16.77
-DI 23.46
Chandelier Exit (Long, 3 ATRs ) 11.40
Chandelier Exit (Short, 3 ATRs ) 12.68
Upper Bollinger Band 13.27
Lower Bollinger Band 10.52
Percent B (%b) 0.17
BandWidth 23.13
MACD Line -0.08
MACD Signal Line 0.02
MACD Histogram -0.1004
Fundamentals Value
Market Cap 142.17 Million
Num Shares 12.9 Million
EPS -99999.99
Price-to-Earnings (P/E) Ratio 0.00
Price-to-Sales 0.00
Price-to-Book 1.81
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 11.80
Resistance 3 (R3) 11.86 11.65 11.66
Resistance 2 (R2) 11.65 11.45 11.62 11.62
Resistance 1 (R1) 11.33 11.33 11.23 11.27 11.57
Pivot Point 11.12 11.12 11.07 11.09 11.12
Support 1 (S1) 10.80 10.92 10.70 10.74 10.43
Support 2 (S2) 10.59 10.80 10.56 10.38
Support 3 (S3) 10.27 10.59 10.34
Support 4 (S4) 10.21